Saturation-Binding Ratiometric Assay for Precise Hb A1c Measurement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current assays for glycated hemoglobin (Hb A1c) suffer from imprecision due to non-specific adsorption and the need for wash steps, which are prone to interference and variability, especially when dealing with undesirable hemoglobin isoforms like HbF.
Innovation Solution
The method employs specific-binding reagents that preferentially bind Hb A1c over unbound forms, allowing saturation binding on a surface, eliminating the need for wash steps and normalizing the measurement by using consistently prepared surfaces like beads, where the amount of bound hemoglobin per unit area is constant, enabling direct measurement of the A1c subpopulation without measuring total hemoglobin.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If non-specific adsorption is used to bind hemoglobin to a solid phase, then the assay can be performed, but the measurement precision deteriorates due to interferences and the need for wash steps
Solution Approach 1:
The patent applies local quality by using specific binding reagents (antibodies) that are selectively affinity-bound to Hb A1c at particular locations on the solid phase surface. This creates localized high-affinity binding sites that specifically recognize and bind only the glycated hemoglobin form, distinguishing it from non-glycated hemoglobin and eliminating the need for wash steps to remove non-specifically bound proteins.
Solution Approach 2:
The patent uses specific binding reagents as intermediary molecules between the solid phase and Hb A1c. These reagents act as mediators that specifically recognize and bind to the unique structure of glycated hemoglobin, enabling selective capture without requiring non-specific adsorption and subsequent wash steps to remove interfering substances.
2Reliability
If wash steps are used to remove unbound A1c, then non-specific binding can be reduced, but the assay complexity and time increase
Solution Approach 1:
The patent applies preliminary action by pre-coating the solid phase with specific binding reagents that are already in the correct orientation and position to immediately recognize and bind Hb A1c upon sample addition. This pre-prepared state eliminates the need for subsequent wash steps to remove unbound reagents, as the specific binding capacity is already optimized at the time of sample introduction.
3Reliability
If total hemoglobin binding is used, then cross reactivity with HbF can be eliminated, but the measurement of A1c fraction becomes less direct
Solution Approach 1:
The patent applies local quality by using specific binding reagents that are selectively affinity-bound to Hb A1c at particular locations on the solid phase surface. This creates localized high-affinity binding sites that specifically recognize and bind only the glycated hemoglobin form, distinguishing it from non-glycated hemoglobin and eliminating the need for wash steps to remove non-specifically bound proteins.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides high precision and simplifies the assay process, reducing variability and imprecision by normalizing the total hemoglobin measurement, allowing direct determination of the Hb A1c fraction with improved accuracy and reduced complexity.
Implementation Method 1
contacting a surface (e.g., beads or other particles, or well or lateral flow strip surface) bearing first specific binding agent (e.g., antibody) binding total hemoglobin
Implementation Method 2
contacting the sample or bound hemoglobin with an excess of labeled second binding agent specific for A1c
Implementation Method 3
specific binding reagents which have much higher affinity for A1 c in the bound than in the un-bound state
Implementation Method 4
When bound to saturation on the surface, the amount of hemoglobin bound on each bead (or per unit surface area) is then essentially constant
Data Source
AI summary
Methods, devices, and reagents are described for performing ratiometric assays for hemoglobin A1c. The methods involve a direct ratio determination between Hb A1c and normalized total hemoglobin utilizing a saturating amount of hemoglobin so that Hb A1c binds proportionately to a substrate. In some applications, the assay utilizes a proximity label system for signal generation and/or labeled magnetic beads. The methods can be configured as homogeneous or heterogeneous assays.